SurvivorNet on MSN

FDA Approves New Subcutaneous (Under-the-Skin) Option for Keytruda: What It Means for Cancer Patients

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous form of Keytruda for a new 'Under-the-Skin' Option for patients. The subcutaneous form of Keytruda showed to deliver the same ...
CURE

FDA Approves Subcutaneous Keytruda in Adult and Pediatric Solid Tumors

The FDA has granted approval to subcutaneous Keytruda for use in adults and pediatric patients with a solid tumor.
The American Journal of Managed Care

FDA Approves Use of Subcutaneous Pembrolizumab for NSCLC

The FDA approved the use of pembrolizumab (Keytruda; Merck) and berahyaluronidase alfa-pmph (Keytruda Qlex; Merck) for use in patients 12 years and older with solid tumor indications approved for the ...
Healio

FDA approves Tremfya for subcutaneous induction in adults with ulcerative colitis

The FDA has approved a subcutaneous induction regimen of guselkumab for the treatment of adults with moderately to severely ...